Jordi Olloquequi

Talca, ML, Chile

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 85 publications

Cognitive-enhancing drugs in Phase II clinical trials for Alzheimer's disease: emerging therapeutic candidates.

Cognitive-enhancing drugs in Phase II clinical trials for Alzheimer's disease: emerging therapeutic candidates.

Journal: Expert opinion on investigational drugs

Published: July 30, 2026

Cognitive-enhancing drugs in Phase II clinical trials for Alzheimer's disease: emerging therapeutic candidates.

Cognitive-enhancing drugs in Phase II clinical trials for Alzheimer's disease: emerging therapeutic candidates.

Journal: Expert opinion on investigational drugs

Published: July 30, 2026

Epigallocatechin-3-gallate attenuates colistin-induced neuro and nephrotoxicity by preserving mitochondrial function and reducing oxidative stress.

Epigallocatechin-3-gallate attenuates colistin-induced neuro and nephrotoxicity by preserving mitochondrial function and reducing oxidative stress.

Journal: Biochemical pharmacology

Published: February 24, 2026

Natural senotherapeutics in respiratory health: Addressing cellular senescence, inflammaging, and immunosenescence in the aging lung.

Natural senotherapeutics in respiratory health: Addressing cellular senescence, inflammaging, and immunosenescence in the aging lung.

Journal: European journal of pharmacology

Published: October 27, 2025

Licochalcone a enhances cognitive resilience in APP/PS1 Mice by modulating glucose metabolism, Aβ burden, and neuroinflammation.

Licochalcone a enhances cognitive resilience in APP/PS1 Mice by modulating glucose metabolism, Aβ burden, and neuroinflammation.

Journal: GeroScience

Published: September 08, 2025

Colistin-loaded biodegradable nanoparticles as a promising antibacterial medication to reduce colistin-induced toxicity.

Colistin-loaded biodegradable nanoparticles as a promising antibacterial medication to reduce colistin-induced toxicity.

Journal: International journal of pharmaceutics

Published: April 27, 2025

Inbreeding and Gallbladder Cancer Risk: Homozygosity Associations Adjusted for Indigenous American Ancestry, BMI, and Genetic Risk of Gallstone Disease.

Inbreeding and Gallbladder Cancer Risk: Homozygosity Associations Adjusted for Indigenous American Ancestry, BMI, and Genetic Risk of Gallstone Disease.

Journal: Cancers

Published: October 07, 2024

Licochalcone A prevents cognitive decline in a lipopolysaccharide-induced neuroinflammation mice model.

Licochalcone A prevents cognitive decline in a lipopolysaccharide-induced neuroinflammation mice model.

Journal: Molecular medicine (Cambridge, Mass.)

Published: July 31, 2024

From Inhalation to Neurodegeneration: Air Pollution as a Modifiable Risk Factor for Alzheimer's Disease.

From Inhalation to Neurodegeneration: Air Pollution as a Modifiable Risk Factor for Alzheimer's Disease.

Journal: International journal of molecular sciences

Published: May 15, 2024

Unveiling the Significance of HLA and KIR Diversity in Underrepresented Populations.

Unveiling the Significance of HLA and KIR Diversity in Underrepresented Populations.

Journal: Biomedicines

Published: April 29, 2024

JNK signaling and its impact on neural cell maturation and differentiation.

JNK signaling and its impact on neural cell maturation and differentiation.

Journal: Life sciences

Published: March 13, 2024

Licochalcone A: A Potential Multitarget Drug for Alzheimer's Disease Treatment.

Licochalcone A: A Potential Multitarget Drug for Alzheimer's Disease Treatment.

Journal: International journal of molecular sciences

Published: July 25, 2023

Showing 1-12 of 85

Last Updated: 09/26/2026